|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
4.130 -0.010 (-0.242%) | 2022/12 - Final HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 2,005,675 | 1,455,946 | 1,303,945 | 1,408,303 |
| Net Cash from / (used in) Investing Activities | -- | (1,768,979) | (1,513,163) | (443,579) | (4,055,029) |
| Net Cash from / (used in) Financing Activities | -- | (333,171) | 774,269 | (710,200) | 2,961,870 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (96,475) | 717,052 | 150,166 | 315,144 |
| Cash & Cash Equivalents at beginning of period | -- | 1,836,695 | 1,059,269 | 912,244 | 640,842 |
| Effect of Foreign Exchange Rate Changes | -- | 12,640 | 60,374 | (3,141) | (43,742) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,752,860 | 1,836,695 | 1,059,269 | 912,244 |
| Remarks: | Real time quote last updated: 04/10/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,029,354 |
| %Change | 44.896% |
| EPS / (LPS) | HKD 0.291 |
| NBV Per Share ($) | HKD 4.071 |